Cargando…
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
BACKGROUND: Nearly 4 billion doses of the BNT162b2-mRNA and CoronaVac-inactivated vaccines have been administrated globally, yet different vaccine-induced immunity against SARS-CoV-2 variants of concern (VOCs) remain incompletely investigated. METHODS: We compare the immunogenicity and durability of...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893246/ https://www.ncbi.nlm.nih.gov/pubmed/35248996 http://dx.doi.org/10.1016/j.ebiom.2022.103904 |
_version_ | 1784662350147616768 |
---|---|
author | Peng, Qiaoli Zhou, Runhong Wang, Yuewen Zhao, Meiqing Liu, Na Li, Shuang Huang, Haode Yang, Dawei Au, Ka-Kit Wang, Hui Man, Kwan Yuen, Kwok-Yung Chen, Zhiwei |
author_facet | Peng, Qiaoli Zhou, Runhong Wang, Yuewen Zhao, Meiqing Liu, Na Li, Shuang Huang, Haode Yang, Dawei Au, Ka-Kit Wang, Hui Man, Kwan Yuen, Kwok-Yung Chen, Zhiwei |
author_sort | Peng, Qiaoli |
collection | PubMed |
description | BACKGROUND: Nearly 4 billion doses of the BNT162b2-mRNA and CoronaVac-inactivated vaccines have been administrated globally, yet different vaccine-induced immunity against SARS-CoV-2 variants of concern (VOCs) remain incompletely investigated. METHODS: We compare the immunogenicity and durability of these two vaccines among fully vaccinated Hong Kong people. FINDINGS: Standard BNT162b2 and CoronaVac vaccinations were tolerated and induced neutralizing antibody (NAb) (100% and 85.7%) and spike-specific CD4 T cell responses (96.7% and 82.1%), respectively. The geometric mean NAb IC(50) and median frequencies of reactive CD4 subsets were consistently lower among CoronaVac-vaccinees than BNT162b2-vaccinees. CoronaVac did not induce measurable levels of nucleocapsid protein-specific IFN-γ(+) CD4(+) T or IFN-γ(+) CD8(+) T cells compared with unvaccinated. Against VOCs, NAb response rates and geometric mean IC(50) titers against B.1.617.2 (Delta) and B.1.1.529 (Omicron) were significantly lower for CoronaVac (50%, 23.2 and 7.1%, <20) than BNT162b2 (94.1%, 131 and 58.8%, 35.0), respectively. Three months after vaccinations, NAbs to VOCs dropped near to detection limit, along with waning memory T cell responses, mainly among CoronaVac-vaccinees. INTERPRETATION: Our results indicate that vaccinees especially CoronaVac-vaccinees with significantly reduced NAbs may probably face higher risk to pandemic VOCs breakthrough infection. FUNDING: This study was supported by the Hong Kong Research Grants Council Collaborative Research Fund (C7156-20GF and C1134-20GF); the Wellcome Trust (P86433); the National Program on Key Research Project of China (Grant 2020YFC0860600, 2020YFA0707500 and 2020YFA0707504); Shenzhen Science and Technology Program (JSGG20200225151410198 and JCYJ20210324131610027); HKU Development Fund and LKS Faculty of Medicine Matching Fund to AIDS Institute; Hong Kong Innovation and Technology Fund, Innovation and Technology Commission and generous donation from the Friends of Hope Education Fund. Z.C.’s team was also partly supported by the Theme-Based Research Scheme (T11-706/18-N). |
format | Online Article Text |
id | pubmed-8893246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-88932462022-03-04 Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong Peng, Qiaoli Zhou, Runhong Wang, Yuewen Zhao, Meiqing Liu, Na Li, Shuang Huang, Haode Yang, Dawei Au, Ka-Kit Wang, Hui Man, Kwan Yuen, Kwok-Yung Chen, Zhiwei EBioMedicine Articles BACKGROUND: Nearly 4 billion doses of the BNT162b2-mRNA and CoronaVac-inactivated vaccines have been administrated globally, yet different vaccine-induced immunity against SARS-CoV-2 variants of concern (VOCs) remain incompletely investigated. METHODS: We compare the immunogenicity and durability of these two vaccines among fully vaccinated Hong Kong people. FINDINGS: Standard BNT162b2 and CoronaVac vaccinations were tolerated and induced neutralizing antibody (NAb) (100% and 85.7%) and spike-specific CD4 T cell responses (96.7% and 82.1%), respectively. The geometric mean NAb IC(50) and median frequencies of reactive CD4 subsets were consistently lower among CoronaVac-vaccinees than BNT162b2-vaccinees. CoronaVac did not induce measurable levels of nucleocapsid protein-specific IFN-γ(+) CD4(+) T or IFN-γ(+) CD8(+) T cells compared with unvaccinated. Against VOCs, NAb response rates and geometric mean IC(50) titers against B.1.617.2 (Delta) and B.1.1.529 (Omicron) were significantly lower for CoronaVac (50%, 23.2 and 7.1%, <20) than BNT162b2 (94.1%, 131 and 58.8%, 35.0), respectively. Three months after vaccinations, NAbs to VOCs dropped near to detection limit, along with waning memory T cell responses, mainly among CoronaVac-vaccinees. INTERPRETATION: Our results indicate that vaccinees especially CoronaVac-vaccinees with significantly reduced NAbs may probably face higher risk to pandemic VOCs breakthrough infection. FUNDING: This study was supported by the Hong Kong Research Grants Council Collaborative Research Fund (C7156-20GF and C1134-20GF); the Wellcome Trust (P86433); the National Program on Key Research Project of China (Grant 2020YFC0860600, 2020YFA0707500 and 2020YFA0707504); Shenzhen Science and Technology Program (JSGG20200225151410198 and JCYJ20210324131610027); HKU Development Fund and LKS Faculty of Medicine Matching Fund to AIDS Institute; Hong Kong Innovation and Technology Fund, Innovation and Technology Commission and generous donation from the Friends of Hope Education Fund. Z.C.’s team was also partly supported by the Theme-Based Research Scheme (T11-706/18-N). Elsevier 2022-03-03 /pmc/articles/PMC8893246/ /pubmed/35248996 http://dx.doi.org/10.1016/j.ebiom.2022.103904 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Peng, Qiaoli Zhou, Runhong Wang, Yuewen Zhao, Meiqing Liu, Na Li, Shuang Huang, Haode Yang, Dawei Au, Ka-Kit Wang, Hui Man, Kwan Yuen, Kwok-Yung Chen, Zhiwei Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong |
title | Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong |
title_full | Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong |
title_fullStr | Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong |
title_full_unstemmed | Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong |
title_short | Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong |
title_sort | waning immune responses against sars-cov-2 variants of concern among vaccinees in hong kong |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893246/ https://www.ncbi.nlm.nih.gov/pubmed/35248996 http://dx.doi.org/10.1016/j.ebiom.2022.103904 |
work_keys_str_mv | AT pengqiaoli waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT zhourunhong waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT wangyuewen waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT zhaomeiqing waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT liuna waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT lishuang waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT huanghaode waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT yangdawei waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT aukakit waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT wanghui waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT mankwan waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT yuenkwokyung waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong AT chenzhiwei waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong |